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EDITORIAL

The ethical challenges of antimicrobial resistance for Nurse
practitioners
Antimicrobial resistance (AMR) is one of the most challenging world-

(Centers for Disease Control, 2018; Logan & Bonomo, 2016; World

wide health threats facing modern medicine (Centers for Disease

Health Organization, 2018; Zerr et al., 2014).

Control, 2018; Logan & Bonomo, 2016; World Health Organization,

In the long-term, the threat from a postantimicrobial therapy

2018; Zerr et al., 2014). According to the World Health Organization

world is that today's relatively minor infections—including practically

(2018), when antimicrobial drugs are no longer effective at killing

unavoidable exposures to microbes associated with labour and deliv-

infections caused by bacteria, fungi, parasites and viruses, this is

ery—may once again contribute to increased morbidity and mortality

called AMR. AMR leads to drug-resistant infections (World Health

in both developed and in developing countries (Centers for Disease

Organization, 2018). Nurse practitioners need to be leaders in mit-

Control, 2018; Logan & Bonomo, 2016; World Health Organization,

igating risks associated with antimicrobial use, including ethical

2018; Zerr et al., 2014). In developed countries, unchecked AMR may

dilemmas surrounding AMR (Centers for Disease Control, 2018;

impact surgery and chemotherapy because antibiotics used to treat

Logan & Bonomo, 2016; World Health Organization, 2018; Zerr et

infections may no longer be effective (Centers for Disease Control,

al., 2014). For instance, prescribing antimicrobial drugs represents

2018; Logan & Bonomo, 2016; World Health Organization, 2018; Zerr

an ethical dilemma for nurse practitioners, since the health needs

et al., 2014). And in developing countries, unchecked AMR may also

of individual patients must to be balanced against preservation of

co-occur alongside and impact the incidence and prevalence of ex-

effective antimicrobial therapies and concerns for long-term preven-

isting wide-spread infections such as HIV, malaria and tuberculosis

tion of AMR in communities (Basu & Garg, 2018; Johnstone, 2016).

(Centers for Disease Control, 2018; World Health Organization, 2018).
Currently, nurse practitioners are unable to easily and quickly
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screen and diagnose many types of AMR because specimens must
be sent to a centralized diagnostic laboratory for evaluation of
antimicrobial susceptibility that often takes several days of testing (Mitsakakis, Kaman, Elshout, Specht, & Hays, 2018). Until

The prognosis of AMR is increased morbidity and mortality from un-

better bedside diagnostics are available, one of the best means

controlled growth of a microorganism that is resistant to one, or even

of preventing the spread of AMR by nurse practitioners may be

all, available antimicrobial therapies (Centers for Disease Control,

accomplished through a thorough history and physical exam,

2018; Logan & Bonomo, 2016; World Health Organization, 2018;

and by screenings (Ball, Dains, Flynn, Solomon, & Stewart, 2019;

Zerr et al., 2014). In hospital environments, microorganisms that

Hersh, Jackson, & Hicks, 2013). For instance, final diagnosis of a

are resistant to antimicrobial therapies lead to persistent, pervasive

viral upper respiratory illness can usually be made clinically with

nosocomial infections that may be highly contagious, nearly impos-

little or no laboratory testing needed (Ball et al., 2019; Hersh et

sible to treat and possibly lethal (Centers for Disease Control, 2018;

al., 2013). However, if a pre-school age child exhibits a high fever

World Health Organization, 2018; Zerr et al., 2014). To provide qual-

with sudden onset, body aches and fatigue, a primary care pro-

ity care for patients with AMR, three practices are critical (Centers

vider might use other screenings to rule-out a specific alternative

for Disease Control, 2018; Logan & Bonomo, 2016; World Health

differential diagnosis, such as influenza A or B (Ball et al., 2019;

Organization, 2018; Zerr et al., 2014). First, hospitals and outpatient

Hersh et al., 2013). Conversely, if a child presents with a severe

clinical facilities must be (re)designed to prevent the spread of no-

sore throat, without a cough or other upper respiratory symptoms,

socomial infections. Second, additional rapid bedside diagnostics

it may be appropriate to do a rapid strep test to rule-out group A

are required to evaluate antimicrobial susceptibility in real-time as

streptococcus infection (Ball et al., 2019; Muthanna, Salim, Hamat,

part of the decision-making process in prescribing an antimicrobial

Shamsuddin, & Zakariah, 2018). Unfortunately, there is no test to

therapy. Third, more expensive, last-line-of-defence antimicrobials

diagnose an upper respiratory tract infection in an outpatient clin-

will need to be reserved for longer inpatient treatment scenarios

ical setting (Ball et al., 2019). Similarly, the diagnosis for bacterial
sinusitis, acute otitis media or viral bronchitis must be made via
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clinical examination, without the support of diagnostic testing

authority, anticipating ineffectiveness of a narrow-spectrum antibi-

(Ball et al., 2019).

otic and concerned with the risk of prolonged sickness among influential patients, may elect to prescribe a broad-spectrum antibiotic to
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those whom they favour (Basu & Garg, 2018). While such differential
treatment is unethical and could contribute to class bias, it is not beyond reason to foresee a perverse outcome arising from such a mon-

AMR needs to be viewed by nurse practitioners not just as a

etary incentive with the quality of medical care distributed based

primary care issue but also an ethical issue (Basu & Garg, 2018;

upon the resources of patients (Basu & Garg, 2018; Johnstone,

Johnstone, 2016). Nurse practitioners face three ethical chal-

2016). Therefore, nurse practitioners need to be on-guard when

lenges associated with AMR. First, the nurse practitioner must

well-intentioned policies to prevent AMR may lead to unanticipated

identify the safest ways to protect and promote the individual

outcomes of questionable ethical practice.

patient's well-being in the face of the collective threat to human
health represented by AMR. Second, the nurse practitioner must
identify how best to respond to competing needs as the amount
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of AMR increases and the effectiveness of existing antimicrobial
drugs continues to decrease. Third, the nurse practitioner must

AMR brings to the forefront ethical issue that requires a new

balance the moral interest of different people, including future

way of thinking for nurse practitioners, not just about the nature

generations, while deciding and justifying a course of action that

of the ethical issues AMR raises, but about how to best address

“normally” would not be morally acceptable (e.g. refusing to pre-

these moral dilemmas (Johnstone, 2016). The imperatives of tack-

scribe an antimicrobial therapy and relying upon the expectation

ling the gaps in healthcare ethics related to AMR can no longer

that an infection is self limiting). These ethical questions also bring

be ignored by nurse practitioners. New innovative systems and

up important concerns about the sufficiency and suitability of

theoretical frameworks are urgently needed to address the moral

current ethical frameworks to tackle concerns surrounding AMR

issues raised by AMR (Basu & Garg, 2018; Johnstone, 2016). As

(Basu & Garg, 2018; Johnstone, 2016).

the threat from AMR grows, innovative systems and theoretical

An important distinctive feature of AMR is the collective and

frameworks will have a major influence on how the above ques-

reciprocal vulnerability of all people both as the vectors and vic-

tions are addressed. The answers to the above questions will have

tims of AMR organisms (Basu & Garg, 2018; Johnstone, 2016).

a major impact on the types of changes that eventually will need

Nurse practitioners must advocate in healthcare institutions that

to be made to current standards of care. In a postantimicrobial

patients are not just stand-alone discrete individuals—a balance

era, these will describe what counts as “optimal care.” What fu-

must be found between the individual patient and the collective

ture standard of optimal care will look like is unclear. As a vital

health of the community. For instance, some hospitals are try-

part of the primary care workforce, nurse practitioners need to

ing to stop the spread of AMR by encouraging healthcare pro-

start preparing now through collaborative inquiry and education

viders to prescribe narrow-spectrum antibiotics while reserving

for the ethical challenges that remain ahead in guaranteeing just,

broad-spectrum drugs for emergencies or last resort (Ellegård,

humane and socially responsible consideration to the management

Dietrichson, & Anell, 2017). Ellegård et al. (2017) examined pay

and prevention of AMR (Johnstone, 2016).

for performance (P4P)—monetary incentives to reach pre-defined
prescribing targets—as a way to influence prescribers’ choice of

AC K N OW L E D G E M E N T S

antibiotics. Data from eight Swedish healthcare authorities used

None.

the P4P model as a way to encourage prescribers to select narrow-spectrum antibiotics more often in the treatment of children
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with respiratory tract infections (Ellegård et al., 2017). They found
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